Eli Lilly's (LLY) stock experienced significant volatility in pre-market trading on October 30, 2024. The stock dropped as much as $95 per share, reaching lows around $770 before rebounding to over $800 and hitting $850. Traders took advantage of the dips, with some buying shares at $774 and $815. The stock saw a notable 9% bounce off its lows, although it remained down by 6.6% overall. One trader reported a $5,400 gain after selling 100 shares. Options trading also saw activity, with calls bought at $68 now trading around $107. The stock's movement, partly influenced by reactions to Mounjaro, highlights the market's reaction to the perceived value and potential of Eli Lilly's offerings. One trader noted a $75 move from bottom fishing.